Initiation of XIGDUO XR is not recommended in patients with an eGFR between 30 and 45 mL/min/1.73 m2
T2DM is the underlying cause of many complications, among which, cardiovascular diseases (CVDs) are mainly responsible for the high rates of morbidity and mortality
Clinical trial data shows retatrutide produces greater weight loss than either semaglutide or tirzepatide at their respective maximum doses
This might include pairing GLP-1s with targeted supplements like Omega-3 fatty acids or adding a statin to prevent the oxidation and rupture of existing plaque
doi: 10.1038/s41574-018-0048-7 58 BatumKCinarNSahinSCakmakMAKarsidagS
What you may notice: Clothes fitting differently More control around food Decreased cravings Boosted confidence What your medical weight loss plan includes: Dose evaluation (only if needed we never rush titration) Review of digestion, hydration, and movement Reinforcement of balanced nutrition Week 3 priority: Avoiding undereating, which is common but not helpful
